免疫生物研究所の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2011/02/03 | 1,095 | 1,105 | 1,090 | 1,090 | -14 | -1.3% | 300 |
| 2011/02/02 | 1,130 | 1,130 | 1,071 | 1,104 | +32 | +3% | 890 |
| 2011/02/01 | 1,080 | 1,129 | 1,070 | 1,072 | -28 | -2.5% | 650 |
| 2011/01/31 | 1,066 | 1,127 | 1,066 | 1,100 | -30 | -2.7% | 850 |
| 2011/01/28 | 1,125 | 1,130 | 1,056 | 1,130 | ±0 | ±0% | 2,010 |
| 2011/01/27 | 1,140 | 1,150 | 1,130 | 1,130 | -11 | -1% | 810 |
| 2011/01/26 | 1,150 | 1,160 | 1,131 | 1,141 | +7 | +0.6% | 1,030 |
| 2011/01/25 | 1,160 | 1,160 | 1,123 | 1,134 | +26 | +2.3% | 470 |
| 2011/01/24 | 1,071 | 1,160 | 1,071 | 1,108 | +4 | +0.4% | 1,800 |
| 2011/01/21 | 1,167 | 1,167 | 1,090 | 1,104 | -69 | -5.9% | 5,250 |
| 2011/01/20 | 1,196 | 1,211 | 1,169 | 1,173 | -37 | -3.1% | 2,200 |
| 2011/01/19 | 1,290 | 1,290 | 1,190 | 1,210 | -20 | -1.6% | 7,590 |
| 2011/01/18 | 1,180 | 1,300 | 1,150 | 1,230 | +80 | +7% | 13,480 |
| 2011/01/17 | 1,230 | 1,230 | 1,141 | 1,150 | -75 | -6.1% | 7,210 |
| 2011/01/14 | 1,316 | 1,316 | 1,151 | 1,225 | -91 | -6.9% | 4,700 |
| 2011/01/13 | 1,260 | 1,340 | 1,260 | 1,316 | +66 | +5.3% | 6,920 |
| 2011/01/12 | 1,180 | 1,275 | 1,170 | 1,250 | +72 | +6.1% | 7,310 |
| 2011/01/11 | 1,147 | 1,225 | 1,147 | 1,178 | +31 | +2.7% | 10,040 |
| 2011/01/07 | 1,108 | 1,147 | 1,089 | 1,147 | +44 | +4% | 5,150 |
| 2011/01/06 | 1,100 | 1,150 | 1,090 | 1,103 | +13 | +1.2% | 5,120 |
| 2011/01/05 | 1,093 | 1,093 | 1,060 | 1,090 | ±0 | ±0% | 1,500 |
| 2011/01/04 | 1,069 | 1,094 | 1,020 | 1,090 | +47 | +4.5% | 3,100 |
| 2010/12/30 | 1,030 | 1,043 | 1,010 | 1,043 | +13 | +1.3% | 850 |
| 2010/12/29 | 1,048 | 1,054 | 1,030 | 1,030 | -14 | -1.3% | 800 |
| 2010/12/28 | 1,036 | 1,047 | 1,030 | 1,044 | -5 | -0.5% | 920 |
| 2010/12/27 | 1,053 | 1,065 | 1,045 | 1,049 | -1 | -0.1% | 480 |
| 2010/12/24 | 1,065 | 1,070 | 1,026 | 1,050 | -13 | -1.2% | 1,270 |
| 2010/12/22 | 1,033 | 1,078 | 1,031 | 1,063 | +30 | +2.9% | 1,760 |
| 2010/12/21 | 1,055 | 1,060 | 1,033 | 1,033 | -20 | -1.9% | 2,030 |
| 2010/12/20 | 1,095 | 1,095 | 1,036 | 1,053 | +5 | +0.5% | 1,150 |
| 2010/12/17 | 1,022 | 1,080 | 1,022 | 1,048 | +8 | +0.8% | 1,820 |
| 2010/12/16 | 1,042 | 1,056 | 1,027 | 1,040 | -4 | -0.4% | 510 |
| 2010/12/15 | 1,023 | 1,044 | 1,023 | 1,044 | +21 | +2.1% | 590 |
| 2010/12/14 | 1,035 | 1,039 | 1,018 | 1,023 | -10 | -1% | 1,490 |
| 2010/12/13 | 1,022 | 1,035 | 1,018 | 1,033 | -19 | -1.8% | 1,580 |
| 2010/12/10 | 1,055 | 1,055 | 1,030 | 1,052 | +35 | +3.4% | 800 |
| 2010/12/09 | 1,022 | 1,033 | 1,010 | 1,017 | -5 | -0.5% | 1,340 |
| 2010/12/08 | 1,050 | 1,050 | 1,021 | 1,022 | -23 | -2.2% | 1,320 |
| 2010/12/07 | 1,053 | 1,053 | 1,025 | 1,045 | -15 | -1.4% | 1,890 |
| 2010/12/06 | 1,095 | 1,100 | 1,022 | 1,060 | -5 | -0.5% | 3,240 |
| 2010/12/03 | 1,145 | 1,148 | 1,053 | 1,065 | -70 | -6.2% | 5,240 |
| 2010/12/02 | 1,064 | 1,179 | 1,038 | 1,135 | +101 | +9.8% | 9,080 |
| 2010/12/01 | 1,027 | 1,049 | 1,011 | 1,034 | +23 | +2.3% | 1,130 |
| 2010/11/30 | 1,000 | 1,106 | 1,000 | 1,011 | +15 | +1.5% | 4,240 |
| 2010/11/29 | 1,000 | 1,010 | 991 | 996 | -4 | -0.4% | 980 |
| 2010/11/26 | 1,020 | 1,024 | 999 | 1,000 | -4 | -0.4% | 800 |
| 2010/11/25 | 1,004 | 1,019 | 1,003 | 1,004 | -6 | -0.6% | 510 |
| 2010/11/24 | 1,000 | 1,010 | 991 | 1,010 | -10 | -1% | 1,090 |
| 2010/11/22 | 1,020 | 1,036 | 1,015 | 1,020 | +9 | +0.9% | 740 |
| 2010/11/19 | 1,030 | 1,044 | 1,011 | 1,011 | -2 | -0.2% | 990 |
3251～
3300
件表示中 / 3457件
類似銘柄と比較する
現在ご覧いただいている「免疫生物」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 免疫生物 | 50,600円 | +13.4% | -4.0% | 0.00% | 40.97倍 | 3.72倍 |
|
研究用試薬の製販・受託。遺伝子組み換えカイコの基礎研究は休止し、化粧品等応用開発に移行 |
| ＤＥＬＴＡ－Ｐ | 60,300円 | - | - | 0.00% | - | 4.03倍 |
|
創薬ベンチャー。既存の抗がん物質を組み合わせて安全性と有効性を高めた抗がん剤を開発 |
| ソレイジア | 2,800円 | +102.6% | - | 0.00% | - | 2.71倍 |
|
がん柱の創薬ベンチャー。候補品導入後に開発進め権利再導出、製品販売を行うビジネスモデル |
| レナサイエンス | 36,600円 | -53.6% | - | 0.00% | - | 2.90倍 |
|
東北大発創薬ベンチャー。創業者の宮田同大教授が発見した低分子化合物を使い治療薬を開発 |
| クリングル | 66,000円 | +294.2% | - | 0.00% | - | 1.86倍 |
|
細胞の増殖、保護、修復などの機能があるＨＧＦタンパク質を用いて、難治性疾患治療薬を開発 |
市場注目の銘柄
チャート関連のコラム
